Heron Bay Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,379
Closed -$1.05M 82
2025
Q4
$1.05M Sell
19,379
-303
-2% -$14.6K 0.2% 52
2025
Q3
$888K Sell
19,682
-1,425
-7% -$66.6K 0.17% 52
2025
Q2
$977K Sell
21,107
-16,393
-44% -$805K 0.19% 51
2025
Q1
$2.29M Buy
37,500
+26,705
+247% +$1.56M 0.48% 45
2024
Q4
$611K Buy
10,795
+220
+2% +$12.3K 0.13% 57
2024
Q3
$547K Sell
10,575
-1,980
-16% -$92.9K 0.12% 60
2024
Q2
$521K Buy
+12,555
New +$562K 0.11% 61

Other funds holding BMY

Heron Bay Capital Management's BMY Position: Q1 2026 in Review

Heron Bay Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 19,379 shares — an estimated $1.05M sold.

Heron Bay Capital Management first reported a position in BMY in Q2 2024 and held it in 7 quarters. The position peaked at $2.29M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Heron Bay Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Heron Bay Capital Management sold 19,379 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.05M.
  • Heron Bay Capital Management first reported a position in Bristol-Myers Squibb in Q2 2024 and held it in 7 quarters.
  • Heron Bay Capital Management's Bristol-Myers Squibb position peaked at $2.29M in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Heron Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.